Steven Williams, APRN
Adult Health · Winter Garden, FLNPI 1134771025
Payments from drug & device makers
Across 66 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$298
- AbbVie$203
- Novo Nordisk$198
- Calyxo, Inc.$121
- GSK$81
- Exact Sciences$72
- plus $401 from 11 others
What the payments were for
- Food & beverage$1,374100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $298 |
| AbbVie | 9 | $203 |
| Novo Nordisk | 9 | $198 |
| Calyxo, Inc. | 1 | $121 |
| GSK | 4 | $81 |
| Exact Sciences | 3 | $72 |
| Pfizer | 4 | $72 |
| Lilly USA, LLC | 4 | $69 |
| Amgen | 4 | $64 |
| Ultragenyx Pharmaceutical Inc. | 2 | $43 |
| Boehringer Ingelheim | 1 | $31 |
| Dynavax Technologies Corporation | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| Renalytix AI, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,374 in reported general payments places this provider in the 70th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 65 | $1,268 |
| Amlodipine Besylate | 80 | $629 |
| Azelastine Hcl | 26 | $595 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $566 |
| Atorvastatin Calcium | 59 | $545 |
| Omeprazole | 28 | $518 |
| Lisinopril | 63 | $512 |
| Losartan Potassium | 61 | $469 |
| Metformin Hcl | 40 | $355 |
| Tamsulosin Hcl | 23 | $302 |
| Gabapentin | 17 | $279 |
| Metoprolol Succinate | 21 | $266 |
| Escitalopram Oxalate | 18 | $250 |
| Alendronate Sodium | 19 | $226 |
| Levothyroxine Sodium | 32 | $205 |
Paid to pharmacies, not to this prescriber.
Other adult health in Winter Garden
- Jenniffer BatesWinter Garden$19K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.